675590-01-9 Usage
Uses
Used in Organic Synthesis:
3-BROMO-5-(4-TRIFLUOROMETHYLPHENYL)PYRIDINE is used as a building block for the synthesis of various organic compounds due to its ability to participate in a range of chemical reactions.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 3-BROMO-5-(4-TRIFLUOROMETHYLPHENYL)PYRIDINE is utilized as a key intermediate in the development of new pharmaceuticals, leveraging its reactivity in processes such as Suzuki coupling and palladium-catalyzed cross-coupling reactions to create novel drug candidates.
Used in Agrochemical Development:
3-BROMO-5-(4-TRIFLUOROMETHYLPHENYL)PYRIDINE also serves as a valuable component in the creation of new agrochemicals, contributing to the advancement of products for agricultural applications.
It is crucial to handle 3-BROMO-5-(4-TRIFLUOROMETHYLPHENYL)PYRIDINE with care due to potential hazards associated with its use in chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 675590-01-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,5,5,9 and 0 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 675590-01:
(8*6)+(7*7)+(6*5)+(5*5)+(4*9)+(3*0)+(2*0)+(1*1)=189
189 % 10 = 9
So 675590-01-9 is a valid CAS Registry Number.
675590-01-9Relevant articles and documents
POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
-
Page/Page column 37, (2011/04/24)
Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.
DIAZABICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CNS AND OTHER DISORDERS
-
Page 48, (2010/02/06)
The present invention relates to a compounds of formula (I): wherein A, B, D, E and F are defined herein; that are useful in treating central nervous system (CNS) diseases, disorders and conditions, such as but not limited to nicotine addiction, schizophr